FAP and neoplasm: Compared with the rapid tumor progression observed in untreated (Utd) mice, tumors in FAP/IL-15 CAR-T-treated mice exhibited minimal or no growth, suggesting enhanced antitumor activity via precise targeting of FAP-positive cells and IL-15 secretion by effector cells (Fig. 4G–L).